Skip to content

Insider · CIK 0001867666

Louis H. Morrone

officer

Files at ABT (ABBOTT LABORATORIES). First filing Jan 30, 2025, latest Mar 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $490k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ABT: ABBOTT LABORATORIES

ABTOct 9, 2026 · close 99.60

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
51Moderate
ABTsell 6
ABBOTT LABORATORIES
$154k
1,111 shares
-2%+26% from low0% from high
75Notable
ABTsell 4
ABBOTT LABORATORIES
$337k
2,644 shares
-100%+15% from low-2% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 30, 2025ABT
ABBOTT LABORATORIES
FTax withholding
Common shares without par value
-269$134.38$36k66,609Jul 1, 2025
Feb 28, 2025ABT
ABBOTT LABORATORIES
FTax withholding
Common shares without par value
-4,386$135.87$596k67,989Mar 4, 2025
Mar 3, 2025ABT
ABBOTT LABORATORIES
SOpen-market sale
Common shares without par value
-1,111$138.17$154k66,878Mar 4, 2025
Feb 25, 2025ABT
ABBOTT LABORATORIES
AGrant or award
Common shares without par value
+10,232$0.00$072,375Feb 27, 2025
Feb 25, 2025ABT
ABBOTT LABORATORIES
AGrant or award
Option (right to buy)derivative
+38,108$0.00$038,108Feb 27, 2025
Jan 28, 2025ABT
ABBOTT LABORATORIES
SOpen-market sale
Common shares without par valueindirect: Profit Sharing Trust
-2,644$127.39$337k0Jan 30, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Louis H. Morrone: insider trades and track record | InsiderTell